Cargando…
TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting
Zinc finger nucleases (ZFNs) consist of zinc fingers as DNA-binding module and the non-specific DNA-cleavage domain of the restriction endonuclease FokI as DNA-cleavage module. This architecture is also used by TALE nucleases (TALENs), in which the DNA-binding modules of the ZFNs have been replaced...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857828/ https://www.ncbi.nlm.nih.gov/pubmed/24349308 http://dx.doi.org/10.1371/journal.pone.0082539 |
_version_ | 1782295203950886912 |
---|---|
author | Yanik, Mert Alzubi, Jamal Lahaye, Thomas Cathomen, Toni Pingoud, Alfred Wende, Wolfgang |
author_facet | Yanik, Mert Alzubi, Jamal Lahaye, Thomas Cathomen, Toni Pingoud, Alfred Wende, Wolfgang |
author_sort | Yanik, Mert |
collection | PubMed |
description | Zinc finger nucleases (ZFNs) consist of zinc fingers as DNA-binding module and the non-specific DNA-cleavage domain of the restriction endonuclease FokI as DNA-cleavage module. This architecture is also used by TALE nucleases (TALENs), in which the DNA-binding modules of the ZFNs have been replaced by DNA-binding domains based on transcription activator like effector (TALE) proteins. Both TALENs and ZFNs are programmable nucleases which rely on the dimerization of FokI to induce double-strand DNA cleavage at the target site after recognition of the target DNA by the respective DNA-binding module. TALENs seem to have an advantage over ZFNs, as the assembly of TALE proteins is easier than that of ZFNs. Here, we present evidence that variant TALENs can be produced by replacing the catalytic domain of FokI with the restriction endonuclease PvuII. These fusion proteins recognize only the composite recognition site consisting of the target site of the TALE protein and the PvuII recognition sequence (addressed site), but not isolated TALE or PvuII recognition sites (unaddressed sites), even at high excess of protein over DNA and long incubation times. In vitro, their preference for an addressed over an unaddressed site is > 34,000-fold. Moreover, TALE-PvuII fusion proteins are active in cellula with minimal cytotoxicity. |
format | Online Article Text |
id | pubmed-3857828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38578282013-12-12 TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting Yanik, Mert Alzubi, Jamal Lahaye, Thomas Cathomen, Toni Pingoud, Alfred Wende, Wolfgang PLoS One Research Article Zinc finger nucleases (ZFNs) consist of zinc fingers as DNA-binding module and the non-specific DNA-cleavage domain of the restriction endonuclease FokI as DNA-cleavage module. This architecture is also used by TALE nucleases (TALENs), in which the DNA-binding modules of the ZFNs have been replaced by DNA-binding domains based on transcription activator like effector (TALE) proteins. Both TALENs and ZFNs are programmable nucleases which rely on the dimerization of FokI to induce double-strand DNA cleavage at the target site after recognition of the target DNA by the respective DNA-binding module. TALENs seem to have an advantage over ZFNs, as the assembly of TALE proteins is easier than that of ZFNs. Here, we present evidence that variant TALENs can be produced by replacing the catalytic domain of FokI with the restriction endonuclease PvuII. These fusion proteins recognize only the composite recognition site consisting of the target site of the TALE protein and the PvuII recognition sequence (addressed site), but not isolated TALE or PvuII recognition sites (unaddressed sites), even at high excess of protein over DNA and long incubation times. In vitro, their preference for an addressed over an unaddressed site is > 34,000-fold. Moreover, TALE-PvuII fusion proteins are active in cellula with minimal cytotoxicity. Public Library of Science 2013-12-05 /pmc/articles/PMC3857828/ /pubmed/24349308 http://dx.doi.org/10.1371/journal.pone.0082539 Text en © 2013 Yanik et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Yanik, Mert Alzubi, Jamal Lahaye, Thomas Cathomen, Toni Pingoud, Alfred Wende, Wolfgang TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting |
title | TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting |
title_full | TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting |
title_fullStr | TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting |
title_full_unstemmed | TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting |
title_short | TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting |
title_sort | tale-pvuii fusion proteins – novel tools for gene targeting |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857828/ https://www.ncbi.nlm.nih.gov/pubmed/24349308 http://dx.doi.org/10.1371/journal.pone.0082539 |
work_keys_str_mv | AT yanikmert talepvuiifusionproteinsnoveltoolsforgenetargeting AT alzubijamal talepvuiifusionproteinsnoveltoolsforgenetargeting AT lahayethomas talepvuiifusionproteinsnoveltoolsforgenetargeting AT cathomentoni talepvuiifusionproteinsnoveltoolsforgenetargeting AT pingoudalfred talepvuiifusionproteinsnoveltoolsforgenetargeting AT wendewolfgang talepvuiifusionproteinsnoveltoolsforgenetargeting |